RACK1 and cervical squamous cell carcinoma: A report have demonstrated that CCNO is overexpressed in cervical squamous cell carcinoma (CSCC) and RACK1/miR-302b/c/d-3p-mediated CCNO inhibition can dampen the progression of CSCC (Wang and Chen, 2020).